Integrin structure: New twists and turns in dynamic cell adhesion

Immunological Reviews

Volumn 186, Issue , 2002, Pages 125-140

  Amin Arnaout, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; VON WILLEBRAND FACTOR; LIGAND; VITRONECTIN RECEPTOR;

ALPHA CHAIN; BINDING SITE; CELL ADHESION; LIGAND BINDING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DIMERIZATION; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN BINDING;

ANIMALS; CELL ADHESION; DIMERIZATION; HUMANS; INTEGRIN ALPHAVBETA3; INTEGRINS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 0036696097     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.18612.x     Document Type: Review

References (139)

1. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990;75:1037-1050.
2. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992;69:11-25.
3. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem 2000;275:21785-27188.
4. Liu S, Calderwood DA, Ginsberg MH. Integrin cytoplasmic domain-binding proteins. J Cell Sci 2000;113:3563-3571.
5. Juliano RL. Signal transduction by cell adhesion receptors and the cytoskeleton, functions of integrins, cadherins, selectins and immunoglobulin- superfamily members. Annu Rev Pharmacol Toxicol 2002;42:283-323.
6. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol 2000;19:569-580.
7. Sims PJ, Ginsberg MH, Plow EF, Shattil SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem 1991;266:7345-7352.
8. Mould AP, Garratt AN, Puzon-McLaughlin W, Takada Y, Humphries MJ. Regulation of integrin function: evidence that bivalentcation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin α5 β1. Biochem J 1998;331:821-828.
9. Hantgan RR, Paumi C, Rocco M, Weisel JW. Effects of ligand-mimetic peptides Arg-Gly-Asp-X (X = Phe, Trp, Ser) on αIIbβ3 integrin conformation and oligomerization. Biochemistry 1999;38:14461-14474.
10. Erb E-M, Tangemann K, Bohrmann B, Muller B, Engel J. Integrin αIIbβ3 reconstituted into lipid bilayers is non-clustered in its activated state but clusters after fibrinogen binding. Biochemistry 1997;36:7395-7402.
11. Ingber DE. Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol 1997;59:575-599.
12. Yamada KM, Geiger B. Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol 1997;9:76-85.
13. Lee J-O, Rieu P, Arnaout MA, Liddington R. Crystal Structure of the A-domain from the α-subunit of β2 integrin complement receptor type 3 (CR3, CD11b/CD18). Cell 1995;80:631-638.
14. Qu A, Leahy DJ. Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, α1β2) integrin. Proc Natl Acad Sci USA 1995;92:10277-10281.
15. Emsley J, King SL, Bergelson JM, Liddington RC. Crystal structure of the I domain from integrin α2β1. J Biol Chem 1997;272:28512-28517.
16. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by integrin α2β1. Cell 2000;100:47-56.
17. 2+-complexed crystal structures. J Cell Biol 1998;143:1523-1534.
18. Nolte M, Pepinsky RB, Venyaminov S, Koteliansky V, Gotwals PJ, Karpusas M. Crystal structure of the α1β1 integrin I-domain: insights into integrin I-domain function. FEBS Lett 1999;452:379-385.
19. Legge GB, et al. NMR solution structure of the inserted domain of human leukocyte function associated antigen-1. J Mol Biol 2000;295:1251-1264.
20. Xiong JP, Li R, Essafi M, Stehle T, Arnaout MA. An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem 2000;275:38762-38767.
21. Carrell NA, Fitzgerald LA, Steiner B, Erickson HP, Phillips DR. Structure of human platelet membrane glycoproteins IIb and IIIa as determined by electron microscopy. J Biol Chem 1985;260:1743-1749.
22. Parise LV, Phillips DR. Platelet membrane glycoprotein IIb-IIIa complex incorporated into phospholipid vesicles. Preparation and morphology. J Biol Chem 1985;260:1750-1756.
23. Nermut MV, Green NM, Eason P, Yamada SS, Yamada KM. Electron microscopy and structural model of human fibronectin receptor. EMBO J 1988;7:4093-4099.
24. Weisel JW, Nagaswami C, Vilaire G, Bennett JS. Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem 1992;267:16637-16643.
25. Hantgan RR, Braaten JV, Rocco M. Dynamic light scattering studies of α IIb β 3 solution conformation. Biochemistry 1993;32:3935-3941.
26. Takagi J, Erickson HP, Springer TA. C-terminal opening mimics 'inside-out' activation of integrin α5β1. Nat Struct Biol 2001;8:412-416.
27. Tuckwell DS, Humphries MJ, Brass A. A secondary structure model of the integrin α subunit N-terminal domain based on analysis of multiple alignments. Cell Adhes Commun 1994;2:385-402.
28. Springer TA. Folding of the N-terminal, ligand binding region of integrin α-subunits into a β-propeller. Proc Natl Acad Sci USA 1997;94:65-72.
29. Wall MA, et al. The structure of the G protein heterotrimer Gi α 1 β 1 γ 2. Cell 1995;83:1047:1058.
30. Bork P, Doerks T, Springer TA, Snel B. Domains in plexins: links to integrins and transcription factors. Trends Biochem Sci 1999;24:261-263.
31. Downing AK, Knott V, Werner JM, Cardy CM, Campbell ID, Handford PA. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 1996;85:597-605
32. Beglova N, Blacklow SC, Takagi J, Springer TA. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol 2002;9:282-287
33. Xiong JP, et al. Crystal structure of the extracellular segment of integrin αsV β3. Science 2001;294:339-345.
34. Xiong JP, et al. Unpublished observations.
35. Bode W, et al. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J 1988 2002;7:2593-2599.
36. Janowski R, et al. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001;8:316-320.
37. Lam SC. Isolation and characterization of a chymotryptic fragment of platelet glycoprotein IIb-IIIa retaining Arg-Gly-Asp binding activity. J Biol Chem 1992;267:5649-5655.
38. Djaffar I, et al. A new alternative transcript encodes a 60 kDa truncated form of integrin β 3. Biochem J 1994;300:69-74.
39. Brower DL, Brower SM, Hayward DC, Ball EE. Molecular evolution of integrins: genes encoding integrin β subunits from a coral and a sponge. Proc Natl Acad Sci USA 1997;94:9182-9187.
40. Arnaout MA, Michishita M. Genetic abnormalities in leukocyte adhesion molecule deficiency. In: Gupta S, Griscelli C, eds. Concepts in Immunodeficiency Diseases. New York: Wiley & Sons, 1993:191-202.
41. French DL. The molecular genetics of Glanzmann's thrombasthenia. Platelets 1998;9:5-20.
42. Huang C, Lu C, Springer TA. Folding of the conserved domain but not of flanking regions in the integrin β2 subunit requires association with the α subunit. Proc Natl Acad Sci USA 1997;94:3156-3161.
43. Burrows L, Clark K, Mould AP, Humphries MJ. Fine mapping of inhibitory anti-α5 monoclonal antibody epitopes that differentially affect integrin-ligand binding. Biochem J 1999;344:527-533.
44. Zang Q, Lu C, Huang C, Takagi J, Springer TA. The top of the inserted-like domain of the integrin lymphocyte function-associated antigen-1 β subunit contacts the α subunit β-propeller domain near β-sheet 3. J Biol Chem 2000;275:22202-22212.
45. Conte LL, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol 1999;285:2177-2198.
46. McKay BS, Annis DS, Honda S, Christie D, Kunicki TJ. Molecular requirements for assembly and function of a minimized human integrin αIIbβ3. J Biol Chem 1996;271:30544-30547.
47. Arnaout MA. Leukocyte adhesion molecule deficiency: Its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev 1990;114:145-180.
48. Hogg N, Bates PA. Genetic analysis of integrin function in man: LAD - 1 and other syndromes. Matrix Biol 2000;19:211-222.
49. Roos D, Law SK. Hematologically important mutations: leukocyte adhesion deficiency. Blood Cells Mol Dis 2001;27:1000-1004.
50. Peretz H, et al. Glanzmann's thrombasthenia associated with deletion-insertion and alternative splicing in the glycoprotein IIb gene. Blood 1995;85:414-420.
51. Poncz M, et al. Glanzmann thrombasthenia secondary to a Gly273 →Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb. J Clin Invest 1994;93:172-179.
52. Basani RB, Vilaire G, Shattil SJ, Kolodziej MA, Bennett JS, Poncz M. Glanzmann thrombasthenia due to a two amino acid deletion in the fourth calcium-binding domain of α IIb: demonstration of the importance of calcium-binding domains in the conformation of α IIb β 3. Blood 1996;88:167-173.
53. Michishita M, Videm V, Arnaout MA. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell 1993;72:857-867.
54. Stanley P, Bates PA, Harvey J, Bennett RI, Hogg N. Integrin LFA-1 α subunit contains an ICAM-1 binding site in domains V and VI. EMBO J 1994;13:1790-1798.
55. Dickeson SK, Walsh JJ, Santoro SA. Contributions of the I and EF hand domains to the divalent cation- dependent collagen binding activity of the α2β1 integrin. J Biol Chem 1997;272:7661-7668.
56. Lee J-O, Anne-Bankston L, Arnaout MA, Liddington RC. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure 1995;3:1333-1340.
57. Lu C, Shimaoka M, Ferzly M, Oxvig C, Takagi J, Springer TA. An isolated, surface-expressed I domain of the integrin αLβ2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond. Proc Natl Acad Sci USA 2001;98:2387-2392.
58. Kallen J, et al. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol 1999;292:1-9.
59. Loftus JC, Halloran CE, Ginsberg MH, Feigen LP, Zablocki JA, Smith JW. The amino-terminal one-third of α IIb defines the ligand recognition specificity of integrin α IIb β 3. J Biol Chem 1996;271:2033-2039.
60. Honda S, et al. A two-amino acid insertion in the Cys146-Cys167 loop of the αIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding. J Clin Invest 1998;102:1183-1192.
61. Kamata T, Irie A, Tokuhira M, Takada Y. Critical residues of integrin αIIb subunit for binding of αIIbβ3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3). J Biol Chem 1996;271:18610-18615.
62. Basani RB, et al. A naturally occurring mutation near the amino terminus of αIIb defines a new region involved in ligand binding to αIIbβ3. Blood 2000;95:180-188.
63. Mould AP, Burrows L, Humphries MJ. Identification of amino acid residues that form part of the ligand-binding pocket of integrin α5 β1. J Biol Chem 1998;273:25664-25672.
64. Baneres JL, Roquet F, Green M, LeCalvez H, Parello J. The cation-binding domain from the α subunit of integrin α5 β1 is a minimal domain for fibronectin recognition. J Biol Chem 1998;273:24744-24753.
65. Irie A, Kamata T, Puzon-McLaughlin W, Takada Y, Critical amino acid residues for ligand binding are clustered in a predicted b-turn of the third N-terminal repeat in the integrin α4 and α5 subunits. EMBO J 1995;14:5550-5556.
66. Kamata T, Puzon W, Takada Y. Identification of putative ligand-binding sites of the integrin α4β1. Biochem J 1995;305:945-951
67. Schiffer SG, Hemler ME, Lobb RR, Tizard R, Osborn L. Molecular mapping of functional antibody binding sites of α 4 integrin. J Biol Chem 1995;270:14270-14273.
68. Smith JW, Cheresh DA. The Arg-Gly-Asp binding domain of the vitronectin receptor. Amino acid cross linking implicates aminoacid residues 61-203 of the ? subunit. J Biol Chem 1988;263:18726-18731.
69. Smith JW, Ruggeri ZM, Kunicki TJ, Cheresh DA. Interaction of integrins α v β 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites. J Biol Chem 1990;265:12267-12271.
70. Chen LL, Lobb RR, Cuervo JH, Lin K, Adams SP, Pepinsky RB. Identification of ligand binding sites on integrin α4β1 through chemical cross-linking. Biochemistry 1998;37:8743-8753.
71. D'Souza SE, Ginsberg MH, Burke TA, Lam SC-T, Plow EF. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science (Washington) 1988;242:91-93.
72. Bitan G, Scheibler L, Greenberg Z, Rosenblatt M, Chorev M. Mapping the integrin α V β 3-ligand interface by photoaffinity crosslinking. Biochemistry 1999;38:3414-3420.
73. Lin EC, et al. Evidence that the integrin β3 and β5 subunits contain a metal ion-dependent adhesion site-like motif but lack an I domain. J Biol Chem 1997;272:14236-14243.
74. Tidswell M, et al. Structure-function analysis of the integrin β 7 subunit: identification of domains involved in adhesion to MAdCAM-1. J Immunol 1997;159:1497-1505.
75. Bitan G, Scheibler L, Mierke DF, Rosenblatt M, Chorev M. Ligand-integrin α v β 3 interaction determined by photoaffinity crosslinking: a challenge to the prevailing model. Biochemistry 2000;39:11014-11023.
76. 2+-binding properties of the platelet IIb ligand-interacting domain. J Biol Chem 1992;267:1001-1007.
77. Baneres JL, Roquet F, Martin A, Parello J. A minimized human integrin α (5) β (1) that retains ligand recognition. J Biol Chem 2000;275:5888-5903.
78. Du X, Ginsberg MH. Integrin α IIb β 3 and platelet function. Thromb Haemost 1997;78:96-100.
79. Xiong JP, et al. crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand. Science 2002;296:151-155.
80. 2-terminal repeats of the α subunit. J Biol Chem 2000;275:20324-20336.
81. Honda S, et al. Ligand binding to integrin α (v) β (3) requires tyrosine 178 in the α (v) subunit. Blood 2001;97:175-182.
82. Zhang XP, et al. A 3 β 1 adhesion to laminin-5 and invasin: critical and differential role of integrin residues clustered at the boundary between α 3 N-terminal repeats 2 and 3. Biochemistry 1999;38:14424-14431.
83. Puzon-McLaughlin W, Kamata T, Takada Y. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin α (IIb) β (3). J Biol Chem 2000;275:7795-7802.
84. D'Souza SE, Ginsberg MH, Burke TA, Plow EF. The ligand binding site of the platelet integrin receptor GP IIb-IIIa is proximal to the second calcium binding domain of its α subunit. J Biol Chem 1990;265:34403446.
85. D'Souza SE, Ginsberg MH, Matsueda GR, Plow EF. A discrete sequence in a platelet integrin is involved in ligand recognition. Nature 1991;350:66-68.
86. Calvete JJ, Mann K, Alvarez MV, Lopez MM, Gonzalez-Rodriguez J. Proteolytic dissection of the isolated platelet fibrinogen receptor, integrin GPIIb/IIIa. Localization of GPIIb and GPIIIa sequences putatively involved in the subunit interface and in intrasubunit and intrachain contacts. Biochem J 1992;282:S23-532.
87. Rivas GA, Gonzalez-Rodriguez J. Calcium binding to human platelet integrin GPIIb/IIIa and to its constituent glycoproteins. Effects of lipids and temperature. Biochem J 1991;276:35-40.
88. Cierniewski CS, et al. Peptide ligands can bind to distinct sites in integrin αIIbβ3 and elicit different functional responses. J Biol Chem 1999;274:16923-16932.
89. Phillips DR, Baughan AK. Fibrinogen binding to human platelet plasma membranes. Identification of two steps requiring divalent cations. J Biol Chem 1983;258:10240-10246.
90. 2+. J Biol Chem 1995;270:26270-26277.
91. 2+ binding site on the β3-integrins that regulates the dissociation rate for RGD ligands. J Biol Chem 1996;271:21745-21751.
92. Dechantsreiter MA, et al. N-Methylated cyclic RGD peptides as highly active and selective α (V) β (3) integrin antagonists. J Med Chem 1999;42:3033-3040.
93. Mehta RJ, et al. Transmembrane-truncated αvβ3 integrin retains high affinity for ligand binding: evidence for an 'inside-out' suppressor? Biochem J 1998;330:861-869.
94. Scarborough RM, et al. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 1993;268:1058-1065.
95. Alonso JL, Makram Essafi M, Xiong J-P, Stehle T, Arnaout MA. Does the integrin αA domain act as a ligand for its βA domain? Current Biology 2002.
96. Goodman TG, Bajt ML. Identifying the putative metal ion-dependent adhesion site in the β2 (CD18) subunit required for αLβ2 and αMβ2 ligand interactions. J Biol Chem 1996;271:23729-23736
97. Puzon-McLanghlin W, Takada Y. Critical residues for ligand binding in an I domain-like structure of the integrin β1 subunit. J Biol Chem 1996;271:20438-20443.
98. Lu C, Shimaoka M, Zang Q, Takagi J, Springer TA. Locking in alternate conformations of the integrin α Lβ 2, I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci USA 2001;98:2393-2398
99. Huth JR, et al. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci USA 2000;97:5231-5236.
100. Hemler ME. Integrin associated proteins. Curr Opin Cell Biol 1998;10:578-585.
101. van Kooyk Y, van Vliet SJ, Figdor CG. The actin cytoskeleton regulates LFA-1 llgand binding through avidity rather than affinity changes. J Biol Chem 1999;274:26869-26877.
102. Yanch RL, Berditchevski F, Harler MB, Reichner J, Hemler ME. Highly stoichiometric, stable, and specific association of integrin α3β1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol Biol Cell 1998;9:2751-2765.
103. Yanez-Mo M, et al. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with α3 β1 integrin localized at endothelial lateral junctions. J Cell Biol 1998;141:791-804.
104. Yauch RL, Hemler ME. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem J 2000;351:629-637.
105. Yauch RL, Kazarov AR, Desai B, Lee RT, Hemler ME. Direct extracellular contact between integrin α (3) β (1) and TM4SF protein CD151. J Biol Chem 2000;275:9230-9238.
106. Simon DI, et al. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J Biol Chem 2000;275:10228-10234.
107. Rubinstein E, Poindessous-Jazat V, Le Naour F, Billard M, Boucheix C. CD9, but not other tetraspans, associates with the β1 integrin precursor. Eur J Immunol 1997;27:1919-1927.
108. Hughes PE, et al. Breaking integrin hinge. J Biol Chem 1996;271:6571-6574.
109. Loster K, Hofmann W, Calvete JJ, Reutter W. Chemical cross-linking detects different conformational arrangements of platelet integrin α IIb β III (gpIIb/IIIa). Biochem Biophys Res Commun 1996;229:454-459.
110. Tsuchida J, Ueki S, Takada Y, Salto Y, Takagi J. The 'ligand-induced conformational change' of α 5 β 1 integrin. Relocation of α 5 subunit to uncover the β 1 stalk region. J Cell Sci 1998;111:1759-1766.
111. Dana N, Fathallah DF, Arnaout MA. Expression of a soluble and functional form of the human β2 integrin CD11b/CD18. Proc Natl Acad Sci USA 1991;88:3106-3110.
112. O'Toole TE. Regulation of integrin affinity states through an NPXY motif in the β subunit cytoplasmic domain. J Biol Chem 1995;270:8553-8558.
113. Humphries MJ. Integrin structure. Biochem Soc Trans 2000;28:311-339.
114. Smith JW, Piotrowicz RS, Mathis D. A mechanism for divalent cation regulation of β 3-integrins. J Biol Chem 1994;269:960-967.
115. Douglass WA, et al. The role of the cysteine-rich region of the β2 integrin subunit in the leukocyte function-associated antigen-1 (LFA-1, αLβ2, CD11a/CD18) heterodimer formation and ligand binding. FEBS Lett 1998;440:414-418.
116. Hyland RH, Douglass WA, Tan SM, Law SK. Chimeras of the integrin β subunit mid-region reveal regions required for heterodimer formation and for activation. Cell Adhes Commun 2001;8:61-69.
117. Lu C, Shimaoka M, Zang Q, Takagi J, Springer TA. Locking in alternate conformations of the integrin αLβ2, I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci USA 2001;98:2393-2398
118. Si-Tahar M, et al. Human neutrophil elastase proteolytically activates the platelet integrin αIIbβ3 through cleavage of the carboxyl terminus of the αIIb subunit heavy chain. Involvement in the potentiation of platelet aggregation. J Biol Chem 1997;272:11636-11647.
119. Pelletier AJ, Kunicki T, Ruggeri ZM, Quaranta V. The activation state of the integrin α IIb β 3 affects outside-in signals leading to cell spreading and focal adhesion kinase phosphorylation. J Biol Chem 1995;270:18133-18140.
120. Du X, et al. Long range propagation of conformational changes in integrin αIIbβ3. J Biol Chem 1993;268:23087-23092.
121. Yan B, Hu DD, Knowles SK, Smith JW. Probing chemical and conformational differences in the resting and active conformers of platelet integrin α (IIb) β (3). J Biol Chem 2000;275:7249-7260.
122. Calvete JJ, Arias J, Alvarez MV, Lopez MM, Henschen A, Gonzalez-Rodriguez J. Further studies on the topography of human platelet glycoprotein IIb. Localization of monoclonal antibody epitopes and the putative glycoprotein IIa- and fibrinogen-binding regions. Biochem J 1991;273:767-775.
123. Delwel GO, Hogervorst F, Sonnenberg A. Cleavage of the α6A subunit is essential for activation of the α6Aβ1 integrin by phorbol 12-myristate 13-acetate. J Biol Chem 1996;271:7293-7296.
124. Jenner L, Husted L, Thirup S, Sottrup-Jensen L, Nyborg J. Crystal structure of the receptorbinding domain of α 2-macroglobulin. Structure 1998;6:595-604.
125. Keizer GD, Visser W, Vliem M, Figdor CG. A monoclonal antibody (NKI-L16) directed against a unique epitope on the α-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J Immunol 1988;140:1393-1400.
126. Pujades C, et al. Defining extracellular integrin α-chain sites that affect cell adhesion and adhesion strengthening without altering soluble ligand binding. Mol Biol Cell 1997;8:2647-2657.
127. Cao Z, Huang K, Horwitz AF. Identification of a domain on the integrin α5 subunit implicated in cell spreading and signaling. J Biol Chem 1998;273:31670-31679.
128. Valentin N, Visentin GP, Newman PJ. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Blood 1995;85:3028-3033.
129. Zang Q, Springer TA. Amino acid residues in the PSI domain and cysteine-rich repeats of the integrin β2 subunit that restrain activation of the integrin αXβ2. J Biol Chem 2001;276:6922-6929.
130. Bajt ML, Loftus JC, Gawaz MP, Ginsberg MH. Characterization of a gain of function mutation of integrin α IIb β 3 (platelet glycoprotein IIb-IIIa). J Biol Chem 1992;267:22211-22216.
131. Chen P, Melchior C, Brons NH, Schlegel N, Caen J, Kieffer N. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human β 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in αIIbβ3 activation. J Biol Chem 2001;176:38628-38635.
132. Calvete JJ. On the structure and function of platelet integrin α IIb β 3, the fibrinogen receptor. Proc Soc Exp Biol Med 1995;108:346-360.
133. Kashiwagi H, et al. A mutation in the extra-cellular cysteine-rich repeat region of the β3 subunit activates integrins αIIbβ3 and αVβ3. Blood 1999;93:2559-2568.
134. Ambo H, et al. Three novel integrin β3 subunit missense mutations (H280P C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients. Biochem Biophys Res Commun 1998;251:763-768.
135. Lu C, Ferzly M, Takagi J, Springer TA. Epitope mapping of antibodies to the C-terminal region of the integrin β (2) subunit reveals regions that become exposed upon receptor activation. J Immunol 2001;166:5629-5637.
136. Luque A, Gomez M, Puzon W, Takada Y, Sanchez-Madrid F, Cabanas C. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common β 1 chain. J Biol Chem 1996;171:11067-11075.
137. Tan SM, et al. Defining the repeating elements in the cysteine-rich region (CRR) of the CD18 integrin β 2 subunit. FEBS Lett 2001;505:27-30.
138. Frelinger ALX, Plow EF, Ginsberg MH. Monoclonal antibodies to ligand-occupied conformers of integrin αIIbβ3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem 1991;266:17106-17111.
139. CCP4, CCP4, Collaborative computational project, 4, Daresbury, UK. Acta Crystallogr D 1994;50:760.